# Dynamic microenvironment-regulated hydrogels releasing celastrol lead to urethral scarless repair

**Authors:** Yangwang Jin, Fei Qin, Ranxing Yang, Wenzhuo Fang, Kaile Zhang, Meng Liu, Ming Yang, Ying Wang, Qiang Fu

PMC · DOI: 10.1016/j.mtbio.2026.102917 · Materials Today Bio · 2026-02-11

## TL;DR

A smart hydrogel that releases celastrol helps repair urethral injuries without scarring by controlling the body's inflammatory and fibrotic responses.

## Contribution

A novel hydrogel that dynamically responds to the urethral microenvironment to enable scarless tissue repair.

## Key findings

- The hydrogel degrades in acidic and oxidative environments, reducing inflammation and oxidative stress.
- Celastrol inhibits fibroblast hyperactivation and collagen overproduction via the TGF-β/NF-κB pathway.
- In animal models, the hydrogel improved urethral repair and reduced stricture formation.

## Abstract

The dynamic pathological microenvironment formed post-urethral injury drives an inflammatory-fibrotic cascade, leading to urethral stricture. Herein, we designed a novel hydrogel dressing (CPT-Cel) to modulate this dynamic urethral microenvironment for scarless reconstruction. The hydrogel responsively degrades and releases its contents upon encountering acidic environments and ROS bursts, interrupting the severe oxidative stress-inflammation cycle and creating a favorable regenerative microenvironment in the early wound phase. The incorporated celastrol continuously releases into the late repair phase, inhibiting the hyperactivation of urethral fibroblasts via the TGF-β/NF-κB pathway in urethral microenviroment, thereby preventing excessive collagen secretion. Furthermore, the dressing, featuring an ECM-mimicking microstructure, effectively adheres to and integrates with the injury site, providing hemostatic and antibacterial functions. In animal models of urethral injury, CPT-Cel accelerated urethral repair within the inflammatory milieu, significantly reduced collagen deposition and ultimately improved stricture outcomes. This study not only validates the core mechanism by which an intelligent drug-loaded hydrogel modulates the dynamic urethral microenvironment but also proposes a new paradigm for urethral tissue engineering.

Image 1

## Linked entities

- **Proteins:** TGFB1 (transforming growth factor beta 1), NFKB1 (nuclear factor kappa B subunit 1)
- **Chemicals:** celastrol (PubChem CID 122724)
- **Diseases:** urethral stricture (MONDO:0002127)

## Full-text entities

- **Genes:** NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, TNF-alpha [NCBI Gene 100009088], SLC4A1 (solute carrier family 4 member 1 (Diego blood group)) [NCBI Gene 6521] {aka AE1, BND3, CD233, CHC, DI, EMPB3}, TGFBR2 (transforming growth factor beta receptor 2) [NCBI Gene 7048] {aka AAT3, FAA3, LDS1B, LDS2, LDS2B, MFS2}, IL-1beta [NCBI Gene 100008990], PECAM1 (platelet and endothelial cell adhesion molecule 1) [NCBI Gene 5175] {aka CD31, CD31/EndoCAM, GPIIA', PECA1, PECAM-1, endoCAM}, VIM (vimentin) [NCBI Gene 7431], GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, PCNA (proliferating cell nuclear antigen) [NCBI Gene 5111] {aka ATLD2}, IL-6 [NCBI Gene 100008733], IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, TGFBR1 (transforming growth factor beta receptor 1) [NCBI Gene 7046] {aka AAT5, ACVRLK4, ALK-5, ALK5, ESS1, LDS1}, CEL (carboxyl ester lipase) [NCBI Gene 1056] {aka BAL, BSDL, BSSL, CELL, CEase, FAP}, SMAD3 (SMAD family member 3) [NCBI Gene 4088] {aka HSPC193, HsT17436, JV15-2, LDS1C, LDS3, MADH3}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, CASP8 (caspase 8) [NCBI Gene 841] {aka ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, MRC1 (mannose receptor C-type 1) [NCBI Gene 4360] {aka CD206, CLEC13D, CLEC13DL, MMR, MRC1L1, bA541I19.1}, COL1A1 (collagen type I alpha 1 chain) [NCBI Gene 1277] {aka CAFYD, EDSARTH1, EDSC, OI1, OI2, OI3}
- **Diseases:** scar hyperplasia (MESH:D002921), stenosis (MESH:D003251), Hemolysis (MESH:D006461), fibrosis (MESH:D005355), wounding (MESH:D014947), Inflammation (MESH:D007249), diabetes (MESH:D003920), Urethral injury (MESH:D014526), mucosal defects (MESH:D052016), hyperplasia (MESH:D006965), necrosis (MESH:D009336), overdose (MESH:D062787), RA (MESH:D001172), urethral obstruction (MESH:D014524), Urethral stenosis (MESH:D014525), death (MESH:D003643), blood coagulation (MESH:D001778), urethral lesion (MESH:D014522), infection (MESH:D007239), epithelial hyperplasia (MESH:D017573), urethral wound infections (MESH:D014946), urinary tract infections (MESH:D014552), cytotoxic (MESH:D064420)
- **Chemicals:** methotrexate (MESH:D008727), CCK-8 (MESH:D012844), N-hydroxysuccinimide (MESH:C001426), water (MESH:D014867), benzene (MESH:D001554), TRIzol (MESH:C411644), catechol (MESH:C034221), SDS (MESH:D012967), CMCS (MESH:C514968), CaCl2 (MESH:D002122), Sirius (MESH:C433343), Calcein-AM (MESH:C085925), paraffin (MESH:D010232), Borax (MESH:C018851), O (MESH:D010100), PI (MESH:D010716), chitosan (MESH:D048271), boronic acid (MESH:D001897), PMA (MESH:D013755), streptomycin (MESH:D013307), pentobarbital sodium (MESH:D010424), 2,2-diphenyl-1-picrylhydrazyl (MESH:C004931), ester (MESH:D004952), BA (MESH:C032688), agar (MESH:D000362), polyphenol (MESH:D059808), iodine (MESH:D007455), W (MESH:D014414), LPS (MESH:D008070), chloroform (MESH:D002725), PVDF (MESH:C024865), hydrogen (MESH:D006859), PLGA (MESH:D000077182), eosin (MESH:D004801), ROS (MESH:D017382), EDC (MESH:C024565), formalin (MESH:D005557), 4',6-diamidino-2-phenylindole (MESH:C007293), Crystal violet (MESH:D005840), H&amp;E (MESH:D006371), propidium iodide (MESH:D011419), H2O2 (MESH:D006861), CPT-Cel (-), 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (MESH:C000613388), penicillin (MESH:D010406), hematoxylin (MESH:D006416), phenylboronic acid (MESH:C010686), PVA (MESH:D011142), Celastrol (MESH:C050414), acetone (MESH:D000096)
- **Species:** Sus scrofa (pig, species) [taxon 9823], Escherichia coli (E. coli, species) [taxon 562], Canis lupus familiaris (dog, subspecies) [taxon 9615], Oryctolagus cuniculus (domestic rabbit, species) [taxon 9986], Tripterygium wilfordii (species) [taxon 458696], Rattus norvegicus (brown rat, species) [taxon 10116], Staphylococcus aureus (species) [taxon 1280], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** HUF — Homo sapiens (Human), Finite cell line (CVCL_ZX95), U23-002A — Mus musculus (Mouse), Hybridoma (CVCL_C5AS), fibroblasts — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0594), THP-1 — Homo sapiens (Human), Childhood acute monocytic leukemia, Cancer cell line (CVCL_0006)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12926572/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12926572/full.md

## References

52 references — full list in the complete paper: https://tomesphere.com/paper/PMC12926572/full.md

---
Source: https://tomesphere.com/paper/PMC12926572